FDA's July update lists 211 newly cleared AI-enabled medical devices, with radiology comprising the majority.
Key Details
- 1211 AI-enabled medical devices cleared by the FDA since September 2024.
- 2About 81% of these updated clearances are radiology software products.
- 3QIH (automated radiological image processing) leads with 58 new clearances.
- 4New de novo authorization for Clairity's Allix5 software which analyzes breast cancer risk from images.
- 5Eight image analyzer products for mammography, ultrasound, and radiographs were reclassified from class III to class II in 2024.
- 6FDA plans to tag devices using foundation models, including LLMs and multimodal AI.
Why It Matters
Radiology continues to be at the forefront of FDA-cleared AI innovation, highlighting the field's rapid adoption of advanced technologies. Monitoring regulatory trends, device reclassifications, and transparency measures is critical for radiology and imaging AI professionals.
Source
AuntMinnie
Related News
•AI in Healthcare
AMA and Investors Push for Responsible, Inclusive AI in Healthcare
The AMA urges deep clinician involvement in healthcare AI development as investor funding and regulatory debates intensify.
•AuntMinnie
MRI Integration Enhances Multimodal AI for Breast Cancer Risk and Detection
Adding MRI to a multimodal AI model significantly improves breast cancer detection and risk prediction.
•Radiology Business
Less than 30% of Radiology AI Devices Undergo Clinical Testing Before FDA Clearance
A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.